Back to Search Start Over

The Canadian Community Utilization of Stroke Prevention Study in Atrial Fibrillation in the Emergency Department (C-CUSP ED).

Authors :
Parkash R
Magee K
McMullen M
Clory M
D'Astous M
Robichaud M
Andolfatto G
Read B
Wang J
Thabane L
Atzema C
Dorian P
Kaczorowski J
Banner D
Nieuwlaat R
Ivers N
Huynh T
Curran J
Graham I
Connolly S
Healey J
Source :
Annals of emergency medicine [Ann Emerg Med] 2019 Apr; Vol. 73 (4), pp. 382-392. Date of Electronic Publication: 2018 Oct 26.
Publication Year :
2019

Abstract

Study Objective: Lack of oral anticoagulation prescription in the emergency department (ED) has been identified as a care gap in atrial fibrillation patients. This study seeks to determine whether the use of a tool kit for emergency physicians with a follow-up community-based atrial fibrillation clinic resulted in greater oral anticoagulation prescription at ED discharge than usual care.<br />Methods: This was a before-after study in 5 Canadian EDs in 3 cities. Patients who presented to the ED with atrial fibrillation were eligible for inclusion. The before phase (1) was retrospective; 2 after phases (2 and 3) were prospective: phase 2 used an oral anticoagulation prescription tool for emergency physicians and patient education materials, whereas phase 3 used the same prescription tool, patient materials, atrial fibrillation educational session, and follow-up in an atrial fibrillation clinic. Each phase was 1 year long. The primary outcome was the rate of new oral anticoagulation prescription at ED discharge for patients who were oral anticoagulation eligible and not receiving oral anticoagulation at presentation.<br />Results: A total of 631 patients were included. Mean age was 69 years (SD 14 years), 47.4% were women, and 69.6% of patients had a CHADS <subscript>2</subscript> score greater than or equal to 1. The rate of new oral anticoagulation prescription in phase 1 was 15.8% compared with 54.1% and 47.2%, in phases 2 and 3, respectively. After multivariable adjustment, the odds ratio for new oral anticoagulation prescription was 8.03 (95% confidence interval 3.52 to 18.29) for phase 3 versus 1. The 6-month rate of oral anticoagulation use was numerically but not significantly higher in phase 3 compared with phase 2 (71.6% versus 79.4%; adjusted odds ratio 2.30; 95% confidence interval 0.89 to 5.96). The rate of major bleeding at 6 months was 0%, 0.8%, and 1% in phases 1, 2, and 3, respectively.<br />Conclusion: An oral anticoagulation prescription tool was associated with an increase in new oral anticoagulation prescription in the ED, irrespective of whether an atrial fibrillation clinic follow-up was scheduled. The use of an atrial fibrillation clinic was associated with a trend to a higher rate of oral anticoagulation at 6-month follow-up.<br /> (Copyright © 2018 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1097-6760
Volume :
73
Issue :
4
Database :
MEDLINE
Journal :
Annals of emergency medicine
Publication Type :
Academic Journal
Accession number :
30502307
Full Text :
https://doi.org/10.1016/j.annemergmed.2018.09.001